De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Hanna L. Kleiboeker, Jillian L. Descourouez, Chris M. Saddler, David Al‐Adra, John P. Rice, Margaret R. Jorgenson |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024)
by: Margaret R. Jorgenson, et al.
Published: (2024)
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
by: John‐Anthony Coppola, et al.
Published: (2025)
by: John‐Anthony Coppola, et al.
Published: (2025)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)
by: Suneri J. Amin, et al.
Published: (2025)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)
by: Abdallah Mughrabi, et al.
Published: (2026)
Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
by: Florence Runyo, et al.
Published: (2025)
by: Florence Runyo, et al.
Published: (2025)
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)
by: Vaisak O. Nair, et al.
Published: (2025)
Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
by: Natasha Banga, et al.
Published: (2025)
by: Natasha Banga, et al.
Published: (2025)
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
by: Lemuel R. Non, et al.
Published: (2024)
by: Lemuel R. Non, et al.
Published: (2024)
De Novo Psoriasis Following Belatacept Therapy in Transplant Recipients: Case Series
by: Grace Y. Im, et al.
Published: (2025)
by: Grace Y. Im, et al.
Published: (2025)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
by: Eishan Ashwat, et al.
Published: (2025)
by: Eishan Ashwat, et al.
Published: (2025)
Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease
by: Domitille Erard, et al.
Published: (2024)
by: Domitille Erard, et al.
Published: (2024)
Reduced Functional Status among Kidney Transplant Recipients over Time and Associated Risks Post‐Transplant
by: Sage L. Dixon, et al.
Published: (2025)
by: Sage L. Dixon, et al.
Published: (2025)
Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients
by: Emilie Høegholm Ernst Lauridsen, et al.
Published: (2026)
by: Emilie Høegholm Ernst Lauridsen, et al.
Published: (2026)
Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
by: Madeleine R. Heldman, et al.
Published: (2024)
by: Madeleine R. Heldman, et al.
Published: (2024)
High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic‐Associated Steatotic Liver Disease
by: Emily A. Leven, et al.
Published: (2026)
by: Emily A. Leven, et al.
Published: (2026)
Neighborhood Deprivation Linked to Medication Level Variability in Liver Transplant Recipients
by: Laila Fozouni, et al.
Published: (2025)
by: Laila Fozouni, et al.
Published: (2025)
Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once‐Daily Tacrolimus Formulations: The BITACORA Study
by: Amado Andrés, et al.
Published: (2026)
by: Amado Andrés, et al.
Published: (2026)
Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
by: Song Peng Ang, et al.
Published: (2025)
by: Song Peng Ang, et al.
Published: (2025)
Optimizing Anesthesia Management in Liver Transplantation With Use of Real Time Frontal Electroencephalogram
by: Gabriel Rice, et al.
Published: (2025)
by: Gabriel Rice, et al.
Published: (2025)
Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
by: Lien‐Chung Wei, et al.
Published: (2025)
by: Lien‐Chung Wei, et al.
Published: (2025)
Exploring the Viability of Matching Marginal Donors With Low Renal Function Recipients in Liver Transplantation
by: Miho Akabane, et al.
Published: (2025)
by: Miho Akabane, et al.
Published: (2025)
Tailoring Liver Transplant Decisions: How Donor–Recipient Age Matching Influences Outcomes
by: Abiha Abdullah, et al.
Published: (2026)
by: Abiha Abdullah, et al.
Published: (2026)
Assessing the Quality of Life in Adult Lung Transplant Recipients Quality of Life Post‐Lung Transplant
by: Bashayer M. Al‐Shweeman, et al.
Published: (2025)
by: Bashayer M. Al‐Shweeman, et al.
Published: (2025)
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium
by: Paulo Lisboa Bittencourt, et al.
Published: (2024)
by: Paulo Lisboa Bittencourt, et al.
Published: (2024)
Intraoperative Cardiac Arrests in Asian Recipients of Liver Transplantation—Second Report After Learning Curve
by: Jisun Choi, et al.
Published: (2024)
by: Jisun Choi, et al.
Published: (2024)
Association of Sedentary Behavior and Physical Activity With the Risk of Post‐Transplant Diabetes Mellitus Among Living Donor Liver Transplant Recipients: A Cross‐Sectional Isotemporal Substitution Analysis
by: Miyuki Ushio, et al.
Published: (2025)
by: Miyuki Ushio, et al.
Published: (2025)
Abdominal Gynecologic Procedures in Pancreas Transplant Recipients
by: Allison Drury, et al.
Published: (2024)
by: Allison Drury, et al.
Published: (2024)
Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
by: Madhumita Rao, et al.
Published: (2025)
by: Madhumita Rao, et al.
Published: (2025)
Association Between Liver Graft to Recipient Weight Ratio and Acute Kidney Injury Following Liver Transplantation: A Historical Cohort Study
by: Maxime Soucy‐Proulx, et al.
Published: (2024)
by: Maxime Soucy‐Proulx, et al.
Published: (2024)
Interplay of Donor–Recipient Relationship and Donor Race in Living Liver Donation in the United States
by: Abdula Al‐Seraji, et al.
Published: (2024)
by: Abdula Al‐Seraji, et al.
Published: (2024)
Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation—A European Registry Study
by: Milan J. Sonneveld, et al.
Published: (2024)
by: Milan J. Sonneveld, et al.
Published: (2024)
The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
by: Qingyong Xu, et al.
Published: (2026)
by: Qingyong Xu, et al.
Published: (2026)
Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
by: Armaan F. Akbar, et al.
Published: (2024)
by: Armaan F. Akbar, et al.
Published: (2024)
Travel Practices and Associated Risks in Adult Thoracic Transplant Recipients: A Monocentric Survey
by: Benoît Henry, et al.
Published: (2025)
by: Benoît Henry, et al.
Published: (2025)
Serum β2‐Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients
by: Sandesh Parajuli, et al.
Published: (2024)
by: Sandesh Parajuli, et al.
Published: (2024)
Risk Factors and Outcomes Associated With the Development of Persistent Acute Kidney Injury in Non‐Renal Solid Organ Transplant Recipients: Systematic Review and Meta‐Analysis
by: Ivan E. Saraiva, et al.
Published: (2024)
by: Ivan E. Saraiva, et al.
Published: (2024)
Correction to “A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients is Feasible and Associated With Lower Post‐Transplant Relapse”
Published: (2025)
Published: (2025)
Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation
by: Javier M. Zamora‐Olaya, et al.
Published: (2024)
by: Javier M. Zamora‐Olaya, et al.
Published: (2024)
Comparison of Sarcopenia Assessment in Liver Transplant Recipients by Computed Tomography Freehand Region‐of‐Interest versus an Automated Deep Learning System
by: William Miller, et al.
Published: (2025)
by: William Miller, et al.
Published: (2025)
Similar Items
-
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
by: Hanna L. Kleiboeker, et al.
Published: (2025) -
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024) -
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
by: John‐Anthony Coppola, et al.
Published: (2025) -
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025) -
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)